A baseline metabolomic signature predicts liver fat response to denifanstat (dfs), a first-in-class, fatty acid synthase (fasn) inhibitor: analysis in fascinate-1 and fascinate-2 clinical studies
HEPATOLOGY（2022）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要